Simulia License renewal(Abaqus)

The Food and Drug Administration is forecasting the renewal of a yearly support and maintenance agreement for Simulia’s Abaqus software, a finite element analysis tool used in engineering simulations. The contract is structured as a single-source renewal, meaning the software is being procured directly through the original provider’s authorized distributor, Immix, without competitive bidding. This renewal ensures uninterrupted access to technical support, software updates, patches, and maintenance services essential for the agency’s research and regulatory analysis activities. The North American Industry Classification System code 511210 indicates this is a software publisher-related procurement, aligning with the FDA’s use of simulation technologies for product evaluation and compliance. The posting date is May 25, 2026, suggesting this is a forward-looking forecast for contract activity likely to occur in the coming fiscal period. Primary points of contact for the acquisition include the CDRH Acquisition Liaison at cdrhacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. The contract does not specify a geographic place of performance, implying the software and services are delivered remotely and accessed digitally across the agency’s facilities.